Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aya Sultan"'
Publikováno v:
Journal of Gynecologic Surgery. 34:159-163
Background: Cervical cancer is often a slowly progressing malignancy that presents in women with a mean age of 51. This case is a highly unusual presentation of metastatic squamous cell ca...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f51df7f15fbdd468969c665d069d16cf
https://doi.org/10.1089/gyn.2017.0115
https://doi.org/10.1089/gyn.2017.0115
Publikováno v:
Histopathology. 59:1274-1277
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8d4db2953da03a32211fad3d2b2f65c
https://doi.org/10.1111/j.1365-2559.2011.03994.x
https://doi.org/10.1111/j.1365-2559.2011.03994.x
Autor:
Aya Sultan, Patricia M. Sokolove
Publikováno v:
Archives of biochemistry and biophysics. 386(1)
A variety of experimental conditions elicit increases in mitochondrial permeability that can be differentiated from the classic cyclosporin A (CsA)-sensitive mitochondrial permeability transition (MPT). For example, butylated hydroxytoluene, signal p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567c111303a2382e355dcc61b011121e
https://pubmed.ncbi.nlm.nih.gov/11361000
https://pubmed.ncbi.nlm.nih.gov/11361000
Autor:
Patricia M. Sokolove, Aya Sultan
Publikováno v:
Archives of biochemistry and biophysics. 386(1)
An assortment of agents can induce mitochondria to undergo a permeability transition, which results in the inner mitochondrial membrane becoming nonselectively permeable to small (1500 Da) solutes. This mitochondrial permeability transition (MPT) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e4a326a02cdeb23e8e2994f4088e39
https://pubmed.ncbi.nlm.nih.gov/11360999
https://pubmed.ncbi.nlm.nih.gov/11360999
Autor:
John K. Chan, Yan C. Wang, Aya Sultan, Branimir I. Sikic, George E. Duran, Brian Francisco, Tuyen K. Kiet
Publikováno v:
Gynecologic Oncology. 125:S131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ad56f1354351e6f5c430b204a5cf7c8
https://doi.org/10.1016/j.ygyno.2011.12.320
https://doi.org/10.1016/j.ygyno.2011.12.320
Autor:
E. Brian Francisco, Branimir I. Sikic, George E. Duran, Aya Sultan, Jonathan S. Berek, Cindy Y. Wang
Publikováno v:
Cancer Research. 71:1401-1401
Identification of novel drug targets in ovarian cancers has focused on expression of genes in the tyrosine kinase family. We have previously shown that the spleen tyrosine kinase (SYK) gene was expressed in 73% of 55 ovarian cancer specimens, compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bc3c11d118d37ac7cea308077e508e6
https://doi.org/10.1158/1538-7445.am2011-1401
https://doi.org/10.1158/1538-7445.am2011-1401
Autor:
Aya Sultan, Cindy Y. Wang, E. Brian Francisco, George E. Duran, Jonathan S. Berek, Branimir I. Sikic
Publikováno v:
Cancer Research. 70:3496-3496
In order to identify novel drug targets in ovarian cancers, we examined our ovarian cancer gene expression microarray data for expression of genes in the tyrosine kinase family. The spleen tyrosine kinase (SYK) gene was expressed in 73% of 55 ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5392394160a7b14ebc9cd6f900e4a8bd
https://doi.org/10.1158/1538-7445.am10-3496
https://doi.org/10.1158/1538-7445.am10-3496